Elopak Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Elopak hat ein Gesamteigenkapital von €329.7M und eine Gesamtverschuldung von €285.6M, wodurch sich der Verschuldungsgrad auf 86.6% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen €1.0B bzw. €680.1M. Elopak Das EBIT des Unternehmens beträgt €103.8M, so dass der Zinsdeckungsgrad 4.7 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von €21.3M.

Wichtige Informationen

86.6%

Verhältnis von Schulden zu Eigenkapital

€285.62m

Verschuldung

Zinsdeckungsgrad	4.7x
Bargeld	€21.33m
Eigenkapital	€329.66m
Gesamtverbindlichkeiten	€680.05m
Gesamtvermögen	€1.01b

Jüngste Berichte zur Finanzlage

Is Elopak (OB:ELO) Using Too Much Debt?

May 13

Is Elopak (OB:ELO) Using Too Much Debt?

Jan 25

Recent updates

Elopak ASA Just Missed Earnings - But Analysts Have Updated Their Models

Nov 02

Elopak's (OB:ELO) Returns On Capital Are Heading Higher

Oct 22

Risks To Shareholder Returns Are Elevated At These Prices For Elopak ASA (OB:ELO)

Sep 14

Here's What Analysts Are Forecasting For Elopak ASA (OB:ELO) After Its Second-Quarter Results

Aug 18

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: ELODie kurzfristigen Aktiva des Unternehmens (€456.0M) übersteigen seine kurzfristigen Passiva (€339.5M).

Langfristige Verbindlichkeiten: ELODie kurzfristigen Vermögenswerte des Unternehmens (€456.0M) übersteigen seine langfristigen Verbindlichkeiten (€340.6M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: ELODie Nettoverschuldung im Verhältnis zum Eigenkapital (80.2%) wird als hoch angesehen.

Schulden abbauen: ELO Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 182.7% auf 86.6% zurückgegangen.

Schuldendeckung: ELODie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (50.3%).

Zinsdeckung: ELODie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (4.7x Coverage) gut gedeckt.

Elopak Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Is Elopak (OB:ELO) Using Too Much Debt?

Is Elopak (OB:ELO) Using Too Much Debt?

Recent updates

Elopak ASA Just Missed Earnings - But Analysts Have Updated Their Models

Third quarter 2024 earnings: EPS misses analyst expectations

Elopak's (OB:ELO) Returns On Capital Are Heading Higher

New minor risk - Shareholder dilution

Risks To Shareholder Returns Are Elevated At These Prices For Elopak ASA (OB:ELO)

Here's What Analysts Are Forecasting For Elopak ASA (OB:ELO) After Its Second-Quarter Results

Second quarter 2024 earnings released: EPS: €0.059 (vs €0.074 in 2Q 2023)

Returns On Capital Are Showing Encouraging Signs At Elopak (OB:ELO)

High number of new directors

Elopak ASA to Report Q4, 2024 Results on Feb 11, 2025

Is Elopak (OB:ELO) Using Too Much Debt?

Upcoming dividend of kr1.46 per share

Consensus EPS estimates increase by 10%

Elopak (OB:ELO) Is Increasing Its Dividend To €1.46

Shareholders Can Be Confident That Elopak's (OB:ELO) Earnings Are High Quality

Full year 2023 earnings: EPS misses analyst expectations

Elopak (OB:ELO) Has Announced That It Will Be Increasing Its Dividend To €1.46

Dividend of kr1.46 announced

Elopak (OB:ELO) Is Looking To Continue Growing Its Returns On Capital

Full year 2023 earnings released: EPS: €0.26 (vs €0.13 in FY 2022)

Elopak ASA Proposes Cash Dividend, Payable on or About May 28, 2024

Is Elopak (OB:ELO) Using Too Much Debt?

Insider recently bought kr250k worth of stock

Elopak ASA to Report Fiscal Year 2023 Final Results on Apr 10, 2024

Chief Marketing Officer recently sold kr264k worth of stock

Consensus EPS estimates increase by 13%

Elopak (OB:ELO) Might Have The Makings Of A Multi-Bagger

Third quarter 2023 earnings released: EPS: €0.07 (vs €0.05 in 3Q 2022)

Investor sentiment improves as stock rises 18%

Elopak ASA to Report Q1, 2024 Results on May 08, 2024

New major risk - Revenue and earnings growth

Elopak ASA (OB:ELO) commences an Equity Buyback Plan under the authorization approved on May 11, 2023.

Second quarter 2023 earnings released: EPS: €0.074 (vs €0.047 in 2Q 2022)

Elopak ASA Announces Board Appointments, Effective August 1, 2023

Consensus EPS estimates increase by 11%

Elopak ASA Approves Dividend, Payable on or About May 24, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of kr0.86 per share at 3.4% yield

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 30%

Less than half of directors are independent

Insider recently sold kr1.6m worth of stock

Elopak ASA Announces Step Down of Jo Lunder as Chairperson of the Board of Directors

Elopak ASA, Annual General Meeting, May 11, 2023

Third quarter 2022 earnings released: EPS: €0.04 (vs €0.04 in 3Q 2021)

Consensus EPS estimates increase by 75%

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

The local management agreed to acquire 100% stake in Elopak, Ao from Elopak ASA (OB:ELO).

Elopak ASA (OB:ELO) commences an Equity Buyback Plan under the authorization approved on May 12, 2022.

Less than half of directors are independent

Elopak ASA Proposes Dividend, Payable on or about 19 May 2022

Elopak ASA Temporarily Suspends All Business Activities in Russia with Immediate Effect

Consensus forecasts updated

Elopak ASA Proposes Dividend for the Year 2021

Full year 2021 earnings: EPS misses analyst expectations

Now 25% undervalued after recent price drop

Nippon Paper Industries Co., Ltd. (TSE:3863) acquired an unknown minority stake in Elopak ASA (OB:ELO).

Elopak ASA has completed an IPO in the amount of NOK 2.6358 billion.

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen